Stocks Taking Center Stage on Wall Street (HLBZ,BLBX,NNVC,CRVS)

The SPY500 has bounced back over 150 points and looks like traders and investors are looking to buy the recent dip. Yesterday’s massive sell off was a result of uncertainty over the future of Evergrande. Chinese officials are expected to stem the spillover from liquidity issues at Evergrande, the country’s largest property developer, before it slams the banking system and bleeds into foreign financial centers. The following stocks have still managed to keep the bears away.

Helbiz Inc (NASDAQ: HLBZ) is currently trading at $35.26 and a whooping surge of over 145%. The company today announced that it has signed a three-year agreement with Amazon to stream Helbiz Live on Amazon Prime Video channels. As per the press release, Helbiz Live content will be available for streaming on all Amazon Prime Video devices with the purchase of a monthly subscription. Over the past 1 month, HLBZ is up over 377% all this while Wall Street battles the uncertainties of September. It would be interesting to see if shorts come in and try to push the stock down or will the bulls prevail.

Another stock that is up over 150% and counting in the last 30 days is Blackboxstocks, Inc (OTCMKTS:BLBX). One of the most dramatic examples of the sudden dominant interest of retail market participants is the massive short squeezes we are seeing in stocks such as GameStop Corp (NYSE:GME) and AMC Entertainment Holdings Inc (NYSE:AMC). This scenario – a raging bull market that casts advantages upon new technology services for market participants – forms the context of the opportunity we highlight here today: Blackboxstocks, Inc (OTCMKTS:BLBX). That’s one of the reasons why a recent analyst research report gave this stock a $10/share price target. Read the full report at HERE

Another stock that currently storming WallStreet  is NanoViricides, Inc. (NYSE:NNVC). NNVC touts itself as a global leader in nanomedicines against viruses. The company today announced that it has completed the process of licensing the human Coronavirus field for drug development and commercialization from TheraCour Pharma, Inc. (“TheraCour”). The Company executed a license agreement for the field comprising anti-viral treatments for coronavirus derived human infections with TheraCour Pharma, Inc. on September 8, 2021 (the “Agreement”). NNVC opened at 5.23$ and went on to hit a high of $7.86 with a market cap of about 80M$.

Next in line to gain attention on Wall Street  is Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS). The reason for today’s surge is favorable data results by AstraZeneca PLC (NASDAQ:AZN) for patients with unresectable, stage 3 non-small cell lung cancer. The results may be positively impacting Corvus Pharmaceuticals, which has a CD73 asset in its pipeline.

Please make sure to read and completely understand our disclaimer at https://www.wallstreetpr.com/disclaimer. We may be compensated for posting this content on our website by EDM Media LLC. For questions, comments or suggestions please contact ir@edm.media.

Published by Alan Masterson

Alan has over 25 years of trading experience in the U.S. equity markets. He began his career in finance working on a program trading desk specializing in over-the-counter stocks. His career progressed from that point to his current position as senior trader on an institutional trading desk. In the evenings, Alan teaches economics at a local community college. He has contributed articles to various publications over the last six years, including feature articles for an economics magazine and various financial blogs. You may contact Alan via his email (alanmasterson@wallstreetpr.com) or his Google+ page (https://plus.google.com/103338576216002376250).

Recent Stories

SignUp Now For Our Featured Newsletter